US › Healthcare

Treace Medical Concepts Inc (TMCI)

US · Healthcare · Medical Devices

$4.74+1.28%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$47.2M
Revenue YoY
-10.2%
Net profit
$-18.0M
Profit YoY
-12.8%
EPS
$-0.28
EPS estimate
$-0.31
Net margin
-38.1%

EPS came in at -0.28 against a street estimate of -0.31 — a beat of 9.7%.

Key statistics

Market cap
$262.1M
Forward P/E
0.0
P/B
3.37
Book value
$1.19
EPS (TTM)
$-0.97
52-week high
$7.78
52-week low
$1.17
50-day MA
$3.90
200-day MA
$3.06
Beta
1.38

Analyst view

Analysts rate Treace Medical Concepts Inc a buy (2 buy, 5 hold, 0 sell out of 7) with an average price target of $4.67.

Shareholding

Insiders
25.35%
Institutions
56.85%

Largest institutional holders

FundStake
Armistice Capital, LLC9.81%
Gagnon Securities LLC8.02%
BlackRock Inc5.15%
Bank of America Corp4.95%
Vanguard Group Inc3.50%
Atlantic Trust Group, LLC2.28%
Vanguard Capital Management, LLC2.25%
State Street Corp1.90%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Treace Medical Concepts Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.